Measurement properties of quality-of-life outcome measures for children and adults with eczema: A systematic review update 2.0.
atopic dermatitis
eczema
measurement properties
patient-reported outcome measures
quality of life
Journal
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
09
02
2023
received:
20
12
2022
accepted:
24
02
2023
medline:
29
3
2023
entrez:
28
3
2023
pubmed:
29
3
2023
Statut:
ppublish
Résumé
A systematic review on measurement properties of patient-reported outcome measures (PROMs) for the assessment of quality of life (QoL) in children and adults with eczema was published in 2016 and updated in 2019. We now aimed to systematically assess the measurement properties of PROMs based on recently published development and validation studies regarding quality-of-life skin- or disease-specific PROMs using the COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) guidelines and integrate these findings with those from the 2019 update. A systematic literature search was conducted in PubMed and Embase. Eligible studies reported on measurement properties of QoL skin- or disease-specific PROMs for the assessment of QoL in children and adults with eczema. The methodological quality of the included studies was evaluated using the COSMIN Risk of Bias checklist. The methodological quality of the included PROMs was judged using updated criteria for good measurement properties, and the quality of evidence was graded. The new evidence was integrated into the results from the 2019 update. Finally, a recommendation for use of the identified PROMs was derived based on all evidence. We identified 12 studies fulfilling our inclusion criteria. Based on the newly generated evidence, the Childhood Atopic Dermatitis Impact Scale-short form (CADIS-SF) for infants and the Skindex for adults can be recommended for use. We identified three new PROMs, which have the potential to be used, but require further validation: the Pediatric Allergic Disease Quality of Life Questionnaire (PADQLQ), the Skindex-Mini, and the Scratch Intensity and Impact Scale (SIIS). All other assessed PROMs still have the opportunity to be recommended for use (except for the Dermatology Life Quality Index (DLQI)) but need further validation. Currently, two PROMs for the assessment of QoL in eczema can be recommended for use: the CADIS-SF for infants and the Skindex for adults. Many PROMs, including the recently developed and/or validated PROMs PADQLQ, Skindex-Mini and SIIS, need further validation.
Types de publication
Systematic Review
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13934Informations de copyright
© 2023 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Références
Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-351. doi:10.1016/j.jaad.2013.10.010
Bylund S, Kobyletzki LB, Svalstedt M, Svensson Å. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol. 2020;100:adv00160-adv00112. doi:10.2340/00015555-3510
Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care. 2017;23(8 Suppl):S115-S123.
Drucker AM, Wang AR, Li W-Q, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26-30. doi:10.1016/j.jid.2016.07.012
Schmitt J, Spuls P, Boers M, et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy. 2012;67(9):1111-1117. doi:10.1111/j.1398-9995.2012.02874.x
Marshall S, Haywood K, Fitzpatrick R. Impact of patient-reported outcome measures on routine practice: a structured review. J Eval Clin Pract. 2006;12(5):559-568. doi:10.1111/j.1365-2753.2006.00650.x
Heinl D, Prinsen CAC, Sach T, et al. Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review. Br J Dermatol. 2017;176(4):878-889. doi:10.1111/bjd.14966
Heinl D, Prinsen CAC, Deckert S, et al. Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review. Allergy. 2016;71(3):358-370. doi:10.1111/all.12806
Gabes M, Tischer C, Apfelbacher C. Measurement properties of quality-of-life outcome measures for children and adults with eczema: an updated systematic review. Pediatr Allergy Immunol. 2020;31(1):66-77. doi:10.1111/pai.13120
Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539-549. doi:10.1007/s11136-010-9606-8
Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737-745. doi:10.1016/j.jclinepi.2010.02.006
Terwee CB, Mokkink LB, Knol DL, Ostelo RWJG, Bouter LM, de Vet HCW. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res. 2012;21(4):651-657. doi:10.1007/s11136-011-9960-1
Schmitt J, Langan S, Deckert S, et al. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol. 2013;132(6):1337-1347. doi:10.1016/j.jaci.2013.07.008
Mokkink LB, de Vet HCW, Prinsen CAC, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1171-1179. doi:10.1007/s11136-017-1765-4
Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147-1157. doi:10.1007/s11136-018-1798-3
Rethlefsen ML, Kirtley S, Waffenschmidt S, et al. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev. 2021;10(1):39. doi:10.1186/s13643-020-01542-z
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
Sheth AP, Blumstein AJ, Rangel SM, Jackson KL, Lai J-S, Paller AS. Three-question Skindex-mini measures quality of life in children with atopic dermatitis. J Am Acad Dermatol. 2022;88:493-495. doi:10.1016/j.jaad.2022.06.1167
Apfelbacher CJ, Heinl D, Prinsen CAC, et al. Measurement properties of adult quality-of-life measurement instruments for eczema: protocol for a systematic review. Syst Rev. 2015;4:48. doi:10.1186/s13643-015-0041-3
Heinl D, Prinsen CAC, Drucker AM, et al. Measurement properties of quality of life measurement instruments for infants, children and adolescents with eczema: protocol for a systematic review. Syst Rev. 2016;5:25. doi:10.1186/s13643-016-0202-z
Gabes M, Knüttel H, Stute P, Apfelbacher CJ. Measurement properties of patient-reported outcome measures (PROMs) for women with genitourinary syndrome of menopause: a systematic review. Menopause. 2019;26(11):1342-1353. doi:10.1097/GME.0000000000001390
Gabes M, Knüttel H, Kann G, Tischer C, Apfelbacher CJ. Measurement properties of patient-reported outcome measures (PROMs) in hyperhidrosis: a systematic review. Qual Life Res. 2022;31(3):671-686. doi:10.1007/s11136-021-02958-3
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi:10.1186/s13643-016-0384-4
Mokkink LB, Prinsen C, Patrick DL, et al. COSMIN methodology for systematic reviews of patient-reported outcome measures (PROMs). User Manual. 2018;78(1):1-78.
Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34-42. doi:10.1016/j.jclinepi.2006.03.012
Gabes M, Chamlin SL, Lai J-S, Cella D, Mancini AJ, Apfelbacher CJ. Development of a validated short-form of the childhood atopic dermatitis impact scale, the CADIS-SF15. J Eur Acad Dermatol Venereol. 2020;34(8):1773-1778. doi:10.1111/jdv.16362
Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647. doi:10.1136/bmj.g7647
Dizon MP, Topham C, Haynes D, Brazil M, Chren M-M, Simpson E. Validity of the Skindex mini in patients with atopic dermatitis. Dermatitis. 2021;33:S131-S133. doi:10.1097/DER.0000000000000820
Gabes M, Apfelbacher C. IDQoL, CDLQI and the 45-item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan: a group discussion study. J Eur Acad Dermatol Venereol. 2021;35(2):458-463. doi:10.1111/jdv.16848
Gabes M, Chamlin SL, Lai J-S, Cella D, Mancini AJ, Apfelbacher CJ. Evaluation of responsiveness and estimation of smallest detectable change and minimal important change scores for the childhood atopic dermatitis impact scale. Br J Dermatol. 2020;182(2):348-354. doi:10.1111/bjd.18204
Heckman CJ, Riley M, Valdes-Rodriguez R, Yosipovitch G. Development and initial psychometric properties of two itch-related measures: scratch intensity and impact, sleep-related itch and scratch. J Invest Dermatol. 2020;140(11):2138-2145.e1. doi:10.1016/j.jid.2020.03.961
Hon KL, Ng WGG, Kung JSC, Cheng NS, Ng DKK, Leung TF. Utility of the pediatric allergic disease quality of life questionnaire for childhood eczema. Br J Dermatol. 2019;181(2):290-295. doi:10.1111/bjd.17710
Mohammadi S, Farajzadeh S, Safizadeh H, et al. Validity and reliability of Persian version of infants' dermatitis quality of life index (IDQOL) questionnaire. IJD. 2020;22(4):139-144. doi:10.22034/ijd.2020.104828
Nagata A, Kazi T, Akter Z, et al. The influence of atopic dermatitis on health-related quality of life in Bangladesh. Int J Environ Res Public Health. 2021;18(21):1-13. doi:10.3390/ijerph182111593
Simpson EL, de Bruin-Weller M, Bansal A, et al. Definition of clinically meaningful within-patient changes in POEM and CDLQI in children 6 to 11 years of age with severe atopic dermatitis. Dermatol Ther (Heidelb). 2021;11(4):1415-1422. doi:10.1007/s13555-021-00543-7
Simpson EL, de Bruin-Weller M, Eckert L, et al. Responder threshold for patient-oriented eczema measure (POEM) and children's dermatology life quality index (CDLQI) in adolescents with atopic dermatitis. Dermatol Ther (Heidelb). 2019;9(4):799-805. doi:10.1007/s13555-019-00333-2
Vilsbøll AW, Kragh N, Hahn-Pedersen J, Jensen CE. Mapping dermatology life quality index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and wellness study. Qual Life Res. 2020;29(9):2529-2539. doi:10.1007/s11136-020-02499-1
Roberts G, Hurley C, Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease. J Allergy Clin Immunol. 2003;111(3):491-497. doi:10.1067/mai.2003.138
He Z, Lu C, Chren M-M, et al. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16. Health Qual Life Outcomes. 2014;12:190. doi:10.1186/s12955-014-0190-4
Lewis-Jones MS, Finlay AY, Dykes PJ. The infants' dermatitis quality of life index. Br J Dermatol. 2001;144(1):104-110. doi:10.1046/j.1365-2133.2001.03960.x
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-216. doi:10.1111/j.1365-2230.1994.tb01167.x
Chren M-M. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433-1440. doi:10.1001/archderm.1997.03890470111018
Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105-110. doi:10.1007/BF02737863
Terwee CB, Jansma EP, Riphagen II, de Vet HCW. Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Qual Life Res. 2009;18(8):1115-1123. doi:10.1007/s11136-009-9528-5